# FDA Inspection 1201216 - Biomat USA, Inc. - March 02, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ef7b14db-f3a3-4606-97e1-0562fd0adabb
Source feed: FDA_Inspections

> FDA Inspection 1201216 for Biomat USA, Inc. on March 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201216
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-03-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201216 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6cfe2666-cef8-4014-a6cf-8128faaa5470)

Company: https://www.keypedia.com/companies/biomat-usa-inc/a275ebed-7a4e-4cb4-adb2-078feaced2c1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d